These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3810100)

  • 21. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of a new macrolide, miocamycin, in 150 patients with otorhinolaryngologic disorders].
    Ursino F; Grosjacques M; Panattoni G; Pardini L; Matteucci F
    Clin Ter; 1987 Jul; 122(1):13-6. PubMed ID: 2973891
    [No Abstract]   [Full Text] [Related]  

  • 23. [The pharmacokinetics of josamycin].
    Wildfeuer A; Lemme JD
    Arzneimittelforschung; 1985; 35(3):639-43. PubMed ID: 4039591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pneumonia in children].
    Nohynek H; Korppi M; Eskola J
    Duodecim; 1992; 108(20):1810-8. PubMed ID: 1345276
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cellular immunity and the tuberculin reaction in bacterial, viral and Mycoplasma pneumonias].
    Suzuyama Y
    Kekkaku; 1983 Oct; 58(10):549-52. PubMed ID: 6663955
    [No Abstract]   [Full Text] [Related]  

  • 27. Open clinical trial of roxithromycin in patients of Plateau Hospitals, Jos in upper and lower respiratory tract infections.
    Okeke EN; Juryit Z; Ikeh EI
    West Afr J Med; 1995; 14(4):238-41. PubMed ID: 8634230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of respiratory tract diseases with antibiotics].
    Rowińska-Zakrzewska E
    Przegl Lek; 1984; 41(5):401-4. PubMed ID: 6473819
    [No Abstract]   [Full Text] [Related]  

  • 29. Causes of atypical pneumonia: results of a 1-year prospective study.
    Marrie TJ; Haldane EV; Noble MA; Faulkner RS; Martin RS; Lee SH
    Can Med Assoc J; 1981 Nov; 125(10):1118-23. PubMed ID: 6275975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
    Lee PI; Wu MH; Huang LM; Chen JM; Lee CY
    J Microbiol Immunol Infect; 2008 Feb; 41(1):54-61. PubMed ID: 18327427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Seropositivity against atypical pneumonia agents demonstrated in patients with community-acquired pneumonia].
    Sayan M; Kilinç O; Yüce A; Uçan ES; Genç S
    Mikrobiyol Bul; 2003 Oct; 37(4):247-53. PubMed ID: 14748261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community-acquired pneumonia in adults.
    Sue DY
    West J Med; 1994 Oct; 161(4):383-9. PubMed ID: 7817549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Josamycin in the treatment of bacterial broncho-pulmonary complications in polychemotherapy for advanced bronchogenic carcinoma].
    Salvati F; Antilli A; Lalli A; Signora M; Mecarocci D; Diana F; Orazi D
    G Ital Chemioter; 1985; 32(2):485-8. PubMed ID: 3833591
    [No Abstract]   [Full Text] [Related]  

  • 34. Roxithromycin in the treatment of pneumonia.
    Peterslund NA; Hänninen P; Schreiner A; Black FT; Hultén V
    J Antimicrob Chemother; 1989 May; 23(5):737-41. PubMed ID: 2759923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of TMS-19-Q and midecamycin for respiratory tract infection by double-blind method].
    Kobayashi H; Nihei T; Takeda H; Kohno K; Saito A; Tomizawa M; Nakayama I; Hiraga Y; Kikuchi K; Yamamoto A
    Kansenshogaku Zasshi; 1985 Feb; 59(2):201-26. PubMed ID: 3925037
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antimicrobial drugs in bronchopulmonary infections].
    Löwenberg A
    Ned Tijdschr Geneeskd; 1988 Mar; 132(10):428-32. PubMed ID: 3347278
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative clinical study of roxithromycin and josamycin for suppurative skin and soft tissue infections by a double-blind method].
    Nohara N; Akagi O; Kanzaki H; Kanamoto A; Ohara A; Ohkawara A; Fukaya T; Kobayashi H; Yasuda H; Tagami H
    Kansenshogaku Zasshi; 1989 Mar; 63(3):203-27. PubMed ID: 2504834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of pneumonias in acute respiratory diseases of diverse etiology].
    Pokrovskiĭ VI; Ostrovkiĭ NN; Lazukina LN; Kashin AM; Astaf'eva NV
    Sov Med; 1976 Jul; (7):103-7. PubMed ID: 1023393
    [No Abstract]   [Full Text] [Related]  

  • 39. [Josamycin in the treatment of ambulatory dental infections].
    Tassinari M; Giannelli G; Palano D; Pastore A; Mincione E; Cantoni E
    Dent Cadmos; 1986 Mar; 54(5):93-4, 97-100. PubMed ID: 3460854
    [No Abstract]   [Full Text] [Related]  

  • 40. Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.
    Chan J; Luft BJ
    Antimicrob Agents Chemother; 1986 Aug; 30(2):323-4. PubMed ID: 3767344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.